deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT03237286

Intravenous Ketamine Plus Neurocognitive Training for Depression

Testing a Synergistic, Neuroplasticity-Based Intervention for Depressive Neurocognition

Sponsor: National Institute of Mental Health (NIMH)

Conditions Depression
Interventions Computer-based Cognitive Training Intravenous ketamine
Updated 19 times since 2017 Last updated: Feb 23, 2024 Started: Dec 1, 2017 Primary completion: Oct 18, 2022 Completion: Oct 18, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Depression, this trial is completed. The trial is conducted by National Institute of Mental Health (NIMH) and has accumulated 19 data snapshots since 2017. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~Sep 2017 – ~Dec 2017 · 3 months · monthly snapshot~Dec 2017 – ~Feb 2018 · 2 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Jan 2019 · 5 months · monthly snapshot~Jan 2019 – ~Apr 2019 · 3 months · monthly snapshot~Apr 2019 – ~Apr 2020 · 12 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Oct 2021 · 7 months · monthly snapshot~Oct 2021 – ~Jan 2022 · 3 months · monthly snapshot~Jan 2022 – ~Sep 2022 · 8 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Jan 2023 · 2 months · monthly snapshot~Jan 2023 – ~Dec 2023 · 11 months · monthly snapshot~Dec 2023 – ~Apr 2024 · 4 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

19 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Apr 2024 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Dec 2023 — Apr 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2023 — Dec 2023 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not Recruiting → Completed

▶ Show 14 earlier versions

  1. Nov 2022 — Jan 2023 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  2. Sep 2022 — Nov 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Jan 2022 — Sep 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  4. Oct 2021 — Jan 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Mar 2021 — Oct 2021 [monthly]

    Recruiting PHASE1_PHASE2

  6. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE1_PHASE2

  7. Apr 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

  8. Apr 2019 — Apr 2020 [monthly]

    Recruiting PHASE1_PHASE2

  9. Jan 2019 — Apr 2019 [monthly]

    Recruiting PHASE1_PHASE2

  10. Aug 2018 — Jan 2019 [monthly]

    Recruiting PHASE1_PHASE2

  11. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE1_PHASE2

  12. Feb 2018 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

  13. Dec 2017 — Feb 2018 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting

  14. Sep 2017 — Dec 2017 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Mental Health (NIMH)
  • Rebecca Price
Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations